Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2008 by University Hospital Tuebingen.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT00800371
First received: December 1, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted

December 1, 2008
December 1, 2008
May 2008
December 2009   (final data collection date for primary outcome measure)
Definition of patients with silent arthritis. [ Time Frame: every three to six months from recruitment to end of study ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Comparison of diagnostic value of MRI and ultrasound. [ Time Frame: every three to six months from recruitment to end of study ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
Diagnostic Value of MRI and Ultrasound in Patients With JIA

Juvenile idiopathic arthritis (JIA) may progress asymptomatically leading to joint destruction despite treatment.

The aim of the observational study is to describe patients with silent arthritis comparing symptoms, clinical findings with results of ultrasound and magnetic resonance imaging (MRI).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Patients with JIA

Juvenile Idiopathic Arthritis
Procedure: intra-articular steroid injection
Steroid injection into otherwise noncontrollable arthritis.
JIA
Patients with JIA
Intervention: Procedure: intra-articular steroid injection
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20
June 2010
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • children without symptoms or with only mild joints swelling or with only minimal limited range of motion

Exclusion Criteria:

  • patients with manifest arthritis
Both
7 Years to 17 Years
No
Contact: Nikolay Tzaribachev, MD +49707129 ext 84711 nikolay.tzaribachev@med.uni-tuebingen.de
Germany
 
NCT00800371
Silent Arthritis PROSPECT 2008
No
Nikolay Tzaribachev, MD, University Children's Hospital
University Hospital Tuebingen
Not Provided
Principal Investigator: Nikolay Tzaribachev, MD University Hospital Tuebingen
University Hospital Tuebingen
November 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP